UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.864

Sortiert nach

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

Cardiovascular research, 2003-04, Vol.58 (1), p.32-45

2003

Link zum Volltext

Verfügbarkeit prüfen

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

Heart (British Cardiac Society), 2002-03, Vol.87 (3), p.220-228

2002

Link zum Volltext

Verfügbarkeit prüfen

Left atrial appendage: structure, function, and role in thromboembolism

Heart, 1999-11, Vol.82 (5), p.547-554

1999

Link zum Volltext

Verfügbarkeit prüfen

Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion

Europace (London, England), 2014-05, Vol.16 (5), p.626-630

2014

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of drug-induced QT interval prolongation : Implications for drug approval and labelling

Drug safety, 2001, Vol.24 (5), p.323-351

2001

Link zum Volltext

Verfügbarkeit prüfen

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

The Lancet (British edition), 1997-03, Vol.349 (9053), p.667-674

1997

Link zum Volltext

Verfügbarkeit prüfen

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II

The Lancet (British edition), 2000-05, Vol.355 (9215), p.1582-1587

2000

Link zum Volltext

Verfügbarkeit prüfen

State of play and future direction with NOACs: An expert consensus

Vascular pharmacology, 2018-07, Vol.106, p.9-21

2018

Link zum Volltext

Verfügbarkeit prüfen

Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction

The Lancet (British edition), 1999-04, Vol.353 (9162), p.1390-1396

1999

Link zum Volltext

Verfügbarkeit prüfen

Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease

Heart (British Cardiac Society), 1997-09, Vol.78 (3), p.273-277

1997

Link zum Volltext

Verfügbarkeit prüfen

Early management of atrial fibrillation to prevent cardiovascular complications

European heart journal, 2014-06, Vol.35 (22), p.1448-1456

2014

Link zum Volltext

Verfügbarkeit prüfen

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs : Clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

Cardiovascular research, 2000-08, Vol.47 (2), p.219-233

2000

Link zum Volltext

Verfügbarkeit prüfen

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

Europace (London, England), 2011-03, Vol.13 (3), p.308-328

2011

Link zum Volltext

Verfügbarkeit prüfen

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

Circulation (New York, N.Y.), 1997-07, Vol.96 (2), p.404-407

1997

Link zum Volltext

Verfügbarkeit prüfen

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Europace (London, England), 2011-05, Vol.13 (5), p.610-625

2011

Link zum Volltext

Verfügbarkeit prüfen

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

European heart journal, 2015-09, Vol.36 (33), p.2239-2245

2015

Link zum Volltext

Verfügbarkeit prüfen

Heart rate variability : Standards of measurement, physiological interpretation, and clinical use

European heart journal, 1996-03, Vol.17 (3), p.354-381

1996

Link zum Volltext

Verfügbarkeit prüfen

Atrial fibrillation in the military patient: a review

Journal of the Royal Army Medical Corps, 2015-09, Vol.161 (3), p.237

2015

Link zum Volltext

Verfügbarkeit prüfen

Clinical relevance of silent atrial fibrillation : Prevalence, prognosis, quality of life, and management

Journal of interventional cardiac electrophysiology, 2000-06, Vol.4 (2), p.369-382

2000

Link zum Volltext

Verfügbarkeit prüfen

Relation of Helicobacter pylori infection and coronary heart disease

British Heart Journal, 1994-05, Vol.71 (5), p.437-439

1994

Link zum Volltext

Verfügbarkeit prüfen

Congenital and acquired long QT syndrome

European heart journal, 2000-08, Vol.21 (15), p.1232-1237

2000

Link zum Volltext

Verfügbarkeit prüfen

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

European heart journal, 2000-08, Vol.21 (15), p.1216-1231

2000

Link zum Volltext

Verfügbarkeit prüfen

The unravelling of primary myocardial impairment in Marfan syndrome by modern echocardiography

Heart, 2009-10, Vol.95 (19), p.1561-1566

2009

Link zum Volltext

Verfügbarkeit prüfen

Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey

Cardiovascular research, 2001-03, Vol.49 (4), p.741-750

2001

Link zum Volltext

Verfügbarkeit prüfen

The Utilization of the Implantable Defibrillator—a European Enigma

European heart journal, 2000-12, Vol.21 (24), p.1998-2004

2000

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.864

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.527)
Mit Volltextzugriff
(1.687)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.063)
Humans
(1.022)
Life Sciences & Biomedicine
(997)
Cardiovascular System & Cardiology
(744)
Cardiac & Cardiovascular Systems
(730)
Male
(504)
Female
(498)
Biological And Medical Sciences
(453)
Medical Sciences
(427)
Middle Aged
(425)
Adult
(324)
Aged
(310)
Electrocardiography
(297)
Heart
(251)
Cardiology. Vascular System
(235)
Technology
(205)
Engineering
(185)
Cardiology And Cardiovascular Medicine
(179)
Atrial Fibrillation
(163)
Engineering, Biomedical
(152)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Heart Journal
(187)
Pacing And Clinical Electrophysiology
(147)
Europace
(104)
Heart
(95)
The American Journal Of Cardiology
(88)
Journal Of The American College Of Cardiology
(77)
British Heart Journal
(72)
Circulation
(60)
Clinical Cardiology
(59)
The Lancet
(51)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development

Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval

Left atrial appendage: structure, function, and role in thromboembolism

Ischaemic stroke prevention in patients with atrial fibrillation and high bleeding risk: opportunities and challenges for percutaneous left atrial appendage occlusion

Evaluation of drug-induced QT interval prolongation : Implications for drug approval and labelling

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial—the Losartan Heart Failure Survival Study ELITE II

State of play and future direction with NOACs: An expert consensus

Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction

Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease

Early management of atrial fibrillation to prevent cardiovascular complications

The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs : Clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention

Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction

Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part II: secondary prevention

Edoxaban vs. warfarin in patients with atrial fibrillation on amiodarone: a subgroup analysis of the ENGAGE AF-TIMI 48 trial

Heart rate variability : Standards of measurement, physiological interpretation, and clinical use

Atrial fibrillation in the military patient: a review

Clinical relevance of silent atrial fibrillation : Prevalence, prognosis, quality of life, and management

Relation of Helicobacter pylori infection and coronary heart disease

Congenital and acquired long QT syndrome

The potential for QT prolongation and proarrhythmia by non-antiarrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology

The unravelling of primary myocardial impairment in Marfan syndrome by modern echocardiography

Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey

The Utilization of the Implantable Defibrillator—a European Enigma

Suchergebnisse filtern